The Centre of Research Excellence (CRE) to Reduce Inequality in Heart Disease focuses on improving the heart health and outcomes of groups and communities i.e. Regional Australians, Indigenous Australians and International Health
Dr Jocasta Ball is a NHMRC/National Heart Foundation of Australia Early Career Fellow within the NHMRC
Centre of Research Excellence to Reduce Inequality in Heart Disease at the Mary MacKillop Institute for
Health Research underthe mentorship of Professor Simon Stewart. Jocasta has a Bachelor of Biomedical
Science (Hons) degree and experience in conducting clinical research projects, particularly randomised controlled trials. Jocasta completed her PhD with Monash University under the supervision of Professor Stewart and
Associate Professor Melinda Carrington at Baker IDI Heart and Diabetes Institute. The focus of her PhD research was optimising the management of patients with atrial fibrillation (AF) with an emphasis on identifying methods of risk delineation.
At the foundation of Jocasta’s PhD was the Standard versus Atrial Fibrillation spEcific managemenT strategY (SAFETY) Trial.
Jocasta received the Monash University School of Public Health and Preventive Medicine PhD Thesis Excellence Award 2014 for “an outstanding PhD thesis and its contribution to research” and was a finalist for the Monash University 2014 Mollie Holman Doctoral Medal for best doctoral thesis.
Jocasta’s major research interests are the epidemiology of AF, delineation of patient risk and the design and management of randomised controlled trials, particularly those involving individualised interventions. Jocasta’s current research continues in the area of AF and in defining patient differences with the aim of designing more individualised AF management.
Dr Ball is involved in the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY), a project of the CRE to Reduce Inequality in Heart Disease.
Stewart S, Ball J, Horowitz JD, Marwick TH, Mahadevan G, Wong C, Abhayaratna WP, Chan YK, Esterman A, Thompson DR, Scuffham PA, Carrington MJ. Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre randomised controlled trial. Lancet 2014; published online 17 November 2014.
Procter NEK, Ball J, Liu S, Hurst N, Nooney V, Goh V, Stafford I, Heresztyn T, Carrington MJ, Ngo D, Hylek EM, Isenberg JS, Chirkov YY, Stewart S, Horowitz JD. Impaired platelet nitric oxide response in patients with new onset atrial fibrillation. Int J Cardiol; In Press.
Ball J, Thompson DR, Ski CF, Carrington MJ, Gerber T, Stewart S. Estimating the current and future prevalence of atrial fibrillation in the Australian adult population. Med J Aust 2014; In Press.
Ball J, Carrington MJ, Thompson DR, Horowitz JD, Stewart S on behalf of the SAFETY Investigators. Post-discharge ECG Holter monitoring in recently hospitalised individuals with chronic atrial fibrillation to enhance therapeutic monitoring and identify potentially predictive phenotypes. Eur J Cardiovasc Nurs 2014; published online 14 August 2014.
Ball J, Carrington MJ, McMurray JJV, Stewart S. Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century. Int J Cardiol 2013; 167: 1807-24.
Ball J, Carrington MJ, Stewart S. Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management? Heart 2013; 99: 542-7.
Ball J, Carrington MJ, Stewart S. Reply: diagnosing vascular mild cognitive impairment with atrial fibrillation remains a challenge. Heart 2013; 99: 819-20.
Ball J, Carrington MJ, Wood KA, Stewart S. Women versus men with chronic atrial fibrillation: insights from the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY). PLoS ONE 2013; 8(5): e65795.
Ball J, Carrington MJ, Stewart S. A new or old solution to an old problem? Eur Heart J 2013; E-letter: published online 11 April, 2013.
Carrington MJ, Ball J, Horowitz JD, Marwick TH, Mahadevan G, Wong C, Abhayaratna WP, Haluska B, Thompson DR, Scuffham PA, Stewart S. Navigating the fine line between benefit and risk in chronic atrial fibrillation: Rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY). Int J Cardiol 2013; 166: 359-65.
Sliwa K, Carrington M, Klug E, Opie L, Ball J, Stewart S. Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: Insights from the Heart of Soweto Study. Heart 2010; 96(23): 1878-82.
Inglis SC, Clark RA, McAlister F, Ball J, Lewinter C, Cullington D, Stewart S, Cleland JGF. Structured telephone support or telemonitoring programs for patients with chronic heart failure. Cochrane Database Syst Rev; 2010 Aug 4(8): CD007228.